Prior Authorization Reform for Autoimmune and Blood Disorders...
To amend the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to require health insurance coverage of drugs indicated for the treatment of autoimmune diseases and certain blood disorders.
HB9192, known as the Prior Authorization Reform for Autoimmune and Blood Disorders Act, aims to change how health insurance plans cover certain drugs used to treat autoimmune diseases and specific blood disorders. This bill proposes to make sure these medications are covered without needing extra approval steps, known as prior authorization.
This change would primarily affect people with autoimmune diseases and blood disorders who rely on specific drugs for treatment. By removing barriers like prior authorization, the bill hopes to make it easier and faster for these patients to get the medicines they need. This could lead to better health outcomes and reduce the burden on both patients and healthcare providers.
HB9192 was introduced on June 8, 2026, and has been referred to the Committee on Energy and Commerce, along with the Committees on Education and Workforce, and Ways and Means. These committees will review the bill and decide its next steps in the legislative process. As of now, it is in the early stages of consideration.
